Jazz Croft1, Jon Heron1, Christoph Teufel2, Mary Cannon3, Dieter Wolke4, Andrew Thompson5, Lotte Houtepen1, Stanley Zammit1,6. 1. Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. 2. Cardiff University Brain Research Imaging Centre, School of Psychology, University of Cardiff, Cardiff, United Kingdom. 3. Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland. 4. Division of Mental Health & Wellbeing, Department of Psychology, University of Warwick, Warwick, United Kingdom. 5. Warwick Medical School, University of Warwick, Warwick, United Kingdom. 6. Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, United Kingdom.
Abstract
Importance: Cross-sectional and longitudinal studies have consistently reported associations between childhood trauma and psychotic experiences and disorders. However, few studies have examined whether the age of exposure or specific trauma types are differently associated with the risk of developing psychotic experiences. Objective: To examine whether exposure to trauma, assessed at multiple age periods between 0 and 17 years of age, is associated with an increased risk of psychotic experiences by age 18 years and whether this association varies according to trauma type as well as age and frequency of exposure. Design, Setting, and Participants: This study used data from the Avon Longitudinal Study of Parents and Children, a large population-based birth cohort in the United Kingdom that recruited women who resided in the Avon Health Authority area and had an expected delivery date between April 1, 1991, and December 31, 1992. Data on psychotic experiences were included in the study, along with trauma variables derived from assessments completed by the parents or self-reported by the participants. The variables represent exposure to any trauma type between ages 0 and 17 years; any trauma type within a distinct age period: early childhood (0-4.9 years), middle childhood (5-10.9 years), or adolescence (11-17 years); specific trauma types between ages 0 and 17 years; and specific trauma types within early childhood, middle childhood, or adolescence. Data were analyzed from January 9, 2017, to November 30, 2017. Main Outcomes and Measures: Suspected or definite psychotic experiences were assessed using the psychosis-like symptoms semistructured interview at age 12 years and then at age 18 years. Results: The sample of 4433 participants included 2504 (56.5%) females, with a mean (SD) age of 17.8 (0.38) years. Exposure to any trauma up to age 17 years was associated with increased odds of psychotic experiences at age 18 years (adjusted odds ratio, 2.91; 95% CI, 2.15-3.93). All trauma types from age 0 to 17 years were associated with an increased odds of psychotic experiences. The population-attributable fraction for childhood and adolescent trauma on psychotic experiences at age 18 years was 45% (95% CI, 25%-60%). Effect sizes for most trauma types were greater for exposure that was more proximal to the outcome, although CIs overlapped with those for more distal trauma. Evidence supported dose-response associations for exposure to multiple trauma types and at multiple age periods. In an analysis aimed at minimizing reverse causality, adolescent trauma was also associated with past-year incident psychotic experiences at age 18 years. Conclusions and Relevance: These findings are consistent with the thesis that trauma could have a causal association with psychotic experiences; if so, identification of modifiable mediators is required to inform prevention strategies.
Importance: Cross-sectional and longitudinal studies have consistently reported associations between childhood trauma and psychotic experiences and disorders. However, few studies have examined whether the age of exposure or specific trauma types are differently associated with the risk of developing psychotic experiences. Objective: To examine whether exposure to trauma, assessed at multiple age periods between 0 and 17 years of age, is associated with an increased risk of psychotic experiences by age 18 years and whether this association varies according to trauma type as well as age and frequency of exposure. Design, Setting, and Participants: This study used data from the Avon Longitudinal Study of Parents and Children, a large population-based birth cohort in the United Kingdom that recruited women who resided in the Avon Health Authority area and had an expected delivery date between April 1, 1991, and December 31, 1992. Data on psychotic experiences were included in the study, along with trauma variables derived from assessments completed by the parents or self-reported by the participants. The variables represent exposure to any trauma type between ages 0 and 17 years; any trauma type within a distinct age period: early childhood (0-4.9 years), middle childhood (5-10.9 years), or adolescence (11-17 years); specific trauma types between ages 0 and 17 years; and specific trauma types within early childhood, middle childhood, or adolescence. Data were analyzed from January 9, 2017, to November 30, 2017. Main Outcomes and Measures: Suspected or definite psychotic experiences were assessed using the psychosis-like symptoms semistructured interview at age 12 years and then at age 18 years. Results: The sample of 4433 participants included 2504 (56.5%) females, with a mean (SD) age of 17.8 (0.38) years. Exposure to any trauma up to age 17 years was associated with increased odds of psychotic experiences at age 18 years (adjusted odds ratio, 2.91; 95% CI, 2.15-3.93). All trauma types from age 0 to 17 years were associated with an increased odds of psychotic experiences. The population-attributable fraction for childhood and adolescent trauma on psychotic experiences at age 18 years was 45% (95% CI, 25%-60%). Effect sizes for most trauma types were greater for exposure that was more proximal to the outcome, although CIs overlapped with those for more distal trauma. Evidence supported dose-response associations for exposure to multiple trauma types and at multiple age periods. In an analysis aimed at minimizing reverse causality, adolescent trauma was also associated with past-year incident psychotic experiences at age 18 years. Conclusions and Relevance: These findings are consistent with the thesis that trauma could have a causal association with psychotic experiences; if so, identification of modifiable mediators is required to inform prevention strategies.
Authors: Russell D Romeo; Rudy Bellani; Ilia N Karatsoreos; Nara Chhua; Mary Vernov; Cheryl D Conrad; Bruce S McEwen Journal: Endocrinology Date: 2006-01-12 Impact factor: 4.736
Authors: Martine van Nierop; Tineke Lataster; Feikje Smeets; Nicole Gunther; Catherine van Zelst; Ron de Graaf; Margreet ten Have; Saskia van Dorsselaer; Maarten Bak; Inez Myin-Germeys; Wolfgang Viechtbauer; Jim van Os; Ruud van Winkel Journal: Schizophr Bull Date: 2014-03 Impact factor: 9.306
Authors: J T W Wigman; R van Winkel; Q A W Raaijmakers; J Ormel; F C Verhulst; S A Reijneveld; J van Os; W A M Vollebergh Journal: Psychol Med Date: 2011-04-11 Impact factor: 7.723
Authors: Bruce I Turetsky; Christian G Kohler; Tim Indersmitten; Mahendra T Bhati; Dorothy Charbonnier; Ruben C Gur Journal: Schizophr Res Date: 2007-06-20 Impact factor: 4.939
Authors: Filippo Varese; Feikje Smeets; Marjan Drukker; Ritsaert Lieverse; Tineke Lataster; Wolfgang Viechtbauer; John Read; Jim van Os; Richard P Bentall Journal: Schizophr Bull Date: 2012-03-29 Impact factor: 9.306
Authors: Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: H L Fisher; A Caspi; R Poulton; M H Meier; R Houts; H Harrington; L Arseneault; T E Moffitt Journal: Psychol Med Date: 2013-01-10 Impact factor: 7.723
Authors: Lotta-Katrin Pries; Jim van Os; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Bochao D Lin; Kristel R van Eijk; Gunter Kenis; Alexander Richards; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz Journal: JAMA Psychiatry Date: 2020-12-01 Impact factor: 21.596
Authors: Nora Penzel; Linda A Antonucci; Linda T Betz; Rachele Sanfelici; Johanna Weiske; Oliver Pogarell; Paul Cumming; Boris B Quednow; Oliver Howes; Peter Falkai; Rachel Upthegrove; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Marlene Rosen; Theresa Haidl; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo R K Salokangas; Christos Pantelis; Stephen J Wood; Nikolaos Koutsouleris; Joseph Kambeitz Journal: Neuropsychopharmacology Date: 2021-03-03 Impact factor: 7.853
Authors: Lisa R Steenkamp; Henning Tiemeier; Koen Bolhuis; Manon H J Hillegers; Steven A Kushner; Laura M E Blanken Journal: Acta Psychiatr Scand Date: 2021-02-16 Impact factor: 6.392
Authors: Jazz Croft; Christoph Teufel; Jon Heron; Paul C Fletcher; Anthony S David; Glyn Lewis; Michael Moutoussis; Thomas H B FitzGerald; David E J Linden; Andrew Thompson; Peter B Jones; Mary Cannon; Peter Holmans; Rick A Adams; Stan Zammit Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2021-12-22